The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Akums Drugs share price crashed almost 7 per cent in intraday trade on the BSE on Wednesday, 22 January, after the company said the Income Tax Department conducted a search at its offices and ...
Growth in CDMO should pick up in the next few quarters given Akums’ healthy order book alongside API prices also settling. EBITDA margins leaped 160bps to 12% as the company curbs losses (down ...
Akums Drugs and Pharmaceuticals Ltd said ... The company’s stock price ended down 7 per cent at ₹581.75, on the BSE, Wednesday. “We have fully cooperated with the officials of I-T Department ...
Akums Drugs share price were higher by over 4.33% from previous day's closing price on December 23. Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com ...
The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.
Akums Drugs and Pharmaceuticals reported a 15% increase in adjusted profit after tax, reaching Rs 66.3 crore for the quarter ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Akums Drugs and Pharmaceuticals, a leader in contract development and manufacturing, has launched dapagliflozin + pioglitazone tablets; an advanced combination therapy designed to tackle the growing ...
The mid-cap stock suffered sharp losses after it informed about an IT search at its premises. "We would like to intimate that the Income Tax Department (IT Department) conducted a search under the ...
We've identified the following companies as similar to Akums Drugs and Pharmaceuticals Ltd because they operate in a related industry or sector. We also considered size, growth, and various ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results